Dr. Redjal on Technological Advances in Neurosurgical Oncology

Navid Redjal, MD, FAANS, director, Neurosurgical Oncology, Capital Institute for Neurosciences, Capital Health Cancer Institute, discusses technological advances that have impacted neurosurgical oncology.

Recent technological developments have drastically altered neurosurgeons approach the care of patients with cancer, Redjal says. For instance, stereotactic radiosurgery has replaced typical surgery in approximately 40% of patients, Redjal adds. Stereotactic radiosurgery is a noninvasive procedure used to deliver radiation to small tumors through non-surgical means.

Additionally, intraoperative planning has allowed surgeons to utilize minimally invasive techniques for patients with tumors that could potentially lead to significant morbidity and cause neurologic disfunction, Redjal concludes.